Literature DB >> 7981571

Cholestatic pruritus: effect of phototherapy on pruritus and excretion of bile acids in urine.

E Rosenthal1, E Diamond, A Benderly, A Etzioni.   

Abstract

Pruritus associated with hepatic cholestasis may cause significant morbidity and its correlation to retention of bile acids in skin is inconsistent. Available treatment modalities are only partially effective and can have several adverse effects. Phototherapy has recently been reported to improve cholestatic pruritus, but has not been evaluated previously in children, and its mechanism is still unclear. We report the outcome of multiple Daylite phototherapy treatments over two years in a seven-year-old child with chronic hepatic cholestasis that was resistant to other therapeutic modalities. Bile acid levels in urine were used as markers of effectiveness in parallel with clinical response. Night phototherapy alone increased the bile acids/creatinine ratio in urine from 1.54 +/- 0.04 mumol/mg at baseline to 2.07 +/- 0.29 mumol/mg. Continuous phototherapy combined with night diuresis raised the ratio further to 2.28 +/- 0.55 mumol/mg. Night diuresis alone had no effect. Continuous phototherapy combined with night diuresis raised the bile acids/creatinine ratio by 44% on the first day and by 61% on the second day, but declined to baseline on the third day of treatment. A marked clinical improvement was noted for one week following two days of phototherapy. This schedule has been repeatedly effective in improving pruritus for approximately one year and may be due to the ability of phototherapy to enhance excretion of bile acids and other possible pruritogens into urine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981571     DOI: 10.1111/j.1651-2227.1994.tb13165.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Refractory pruritus in primary biliary cirrhosis.

Authors:  Nuno Cercas Pinheiro; Rui Tato Marinho; Fernando Ramalho; José Velosa
Journal:  BMJ Case Rep       Date:  2013-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.